|
End-of-day quote
Korea S.E.
17/11/2026
|
5-day change | 1st Jan Change | ||
| 2,13,000.00 KRW | -0.70% |
|
+1.43% | +23.56% |
| 10/11 | Celltrion's Stekima Wins EU Backing for Expanded Use in Children | MT |
| 03/11 | Celltrion Gets European Approval for Rheumatoid Arthritis Drug Trial | MT |
Chart: Technical Analysis
Korea S.E.KRW
| Markets | Quality | ||
|---|---|---|---|
Korea S.E.
| A068270 | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 2,15,000 | 2,15,000 | 2,30,476 |
| Spread/Res. | -0.93% | -0.93% | -7.58% |
| Spread/Supp. | +7.47% | +12.94% | +28.39% |
| Support | 1,98,200 | 1,88,600 | 1,65,900 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- A068270 Stock
- Charts Celltrion, Inc.
Select your edition
All financial news and data tailored to specific country editions
















